Table of Contents Table of Contents
Previous Page  53 / 166 Next Page
Information
Show Menu
Previous Page 53 / 166 Next Page
Page Background

INTERNATIONAL STAKEHOLDER PANEL ON ALTERNATIVE

METHODS (ISPAM)

Joe Boison, Ph.D.

Canadian Food Inspection Agency (CFIA)

Working Group Chair

Dr. Boison is a Senior Research Scientist with the Canadian Food Inspection

Agency (CFIA), and holds 2 Adjunct Professor Faculty positions (one in the

Chemistry Department and the other in the Department of Veterinary

Biomedical Sciences) at the University of Saskatchewan. In 2003, he was

appointed a Fellow of the World Innovation Foundation (FWIF), was awarded

the CFIA President’s National Award for Leadership Excellence in 2010 and in

2012, he was appointed a Fellow of the AOACI.

Dr. Boison has been a member of the Food Safety Research Network Team responsible for reviewing and

evaluating research proposals submitted by scientists from Agriculture & Agri-Food Canada and the

Canadian Food Inspection Agency for funding considerations. He is an executive member of the

Spectroscopy Society of Canada, a member of the Standards and Measurement Committee for the

American Society for Mass Spectrometry (ASMS), a member of the AOAC International, and a member of

the Canadian Delegation to the Codex Committee on Residues of Veterinary Drugs in foods (CCRVDF).

Dr. Boison is regularly consulted within and outside Government (primary producers, program managers,

test kit manufacturers, fellow scientists) with regards to residue testing methods for in-plant and on-farm

use. In his current role as AOAC International’s General Referee (GR) on Veterinary Drugs, Dr. Boison

authors an annual review paper on the methods of analysis used in the regulatory analysis of veterinary

drugs.

Dr. Boison’s research and academic interests include development of chromatographic and mass

spectrometric methods for the identification and confirmation of veterinary drug residues in biological

fluids and tissues in support of regulatory enforcement and/or for pharmacokinetic and pharmacodynamic

studies. 2. Development and adaptation of commercially available rapid tests for field and laboratory

screening of drug residues in biological fluids and tissues. 3. Automation of laboratory methods for the

analysis of veterinary and human drugs. 4. Teaching and development of graduate and undergraduate

students to acquire expertise in bio-analytical mass spectrometry, metabolism and pharmacokinetic

studies.